INFUSYSTEM HOLDINGS, INC Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory
INFUSYSTEM HOLDINGS, INC (INFU) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory of $74.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset › Business Combination, Recognized Asset Acquired, Asset, Current
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory · last filed 2023-03-16
- 2022-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $74.00K.
- 2022-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $74.00K.
- 2021-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $74.00K.
- 2021-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $74.00K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory |
|---|---|
| 2022-09-30 | $74.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $74.00K 10-Q · filed 2022-08-04 |
| 2021-12-31 | $74.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $74.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $74.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |